CLASS I ONGOING Drug recall · Reported 14 Jan 2026 · FDA Enforcement Report
ReBoost Nasal Spray recalled by Medinatura New Mexico
Medinatura New Mexico is recalling ReBoost Nasal Spray, distributed nationwide in the US. The recall was initiated on 12 Dec 2025 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0288-2026
- FDA event ID
- 98095
- Recalling firm
- Medinatura New Mexico, Albuquerque, NM
- Brand
- Reboost
- Manufacturer
- MediNatura
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- 12 Dec 2025
- FDA classified
- 15 Jan 2026
- Reported
- 14 Jan 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Reason category
- Mold
- Drug class
- Nasal Sprays
Timeline
| 12 Dec 2025 | Recall initiated by company | |
| 14 Jan 2026 | Published in enforcement report | +33 days |
| 15 Jan 2026 | Classified by FDA | +1 day |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
Product as listed by the FDA
ReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4005-9, UPC 787647101863
Where it was distributed
Nationwide in the US
Questions about this recall
Why was it recalled?
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
Which lots are affected?
All lots within expiry.
Where was it sold?
Nationwide in the US
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 2 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 98095This product is part of a recall event; the main page for the event is ClearLife Allergy Nasal Spray, Extra Strength recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS I | ClearLife Allergy Nasal Spray, Extra Strength recalledClearlife Extra Strength | Medinatura New Mexico | Mold | Nationwide |
More recalls from Medinatura New Mexico
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | ClearLife Allergy Nasal Spray, Extra Strength recalledClearlife Extra Strength | Medinatura New Mexico | Mold | Nationwide |